GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.
For investor information, please contact IR@genmarkdx.com.
Aug 6, 2015
GenMark Diagnostics Reports Q2 Financial Results
Aug 13, 2015 at 8:30 AM ET
35th Annual Canaccord Genuity Growth Conference
Aug 6, 2015 at 1:30 PM PT
GenMark Diagnostics Second Quarter Earnings Conference Call